It is a chemicals private limited company based in Dehradun, Uttarakhand, India, established in 2019.
2019 | Dehradun, Uttarakhand, India | ActiveDegenerica Pharmaceuticals Private Limited, a active private limited company, was established on 18 February 2019 in Dehradun, Uttarakhand, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24294UR2019PTC009533. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Parminder Singh Rattan (Director), Ekta Semwal (Director), Sunil Semwal (Director). Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 1St Floor, Semwal Villa, Sarvpriya Vihar Lane No.2, Near Ugb Balawala, Dehradun, Uttarakhand, 248001.
U24294UR2019PTC009533
009533
18 February 2019
₹0.10 M
₹0.10 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Degenerica Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parminder Singh Rattan | Director | 19 Sep 2020 | Current |
| Ekta Semwal | Director | 18 Feb 2019 | Current |
| Sunil Semwal | Director | 18 Feb 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Degenerica Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 5.67% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Degenerica Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Degenerica Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Degenerica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Degenerica Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Degenerica Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Degenerica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Uttarakhand. was recorded as a recent event.
The activity Parminder Singh Rattan was appointed as a Director was appointed as a Director on 19 Sep 2020 & has been associated with this company since 5 years 2 months . was completed.
The activity Ekta Semwal was appointed as a Director was appointed as a Director on 18 Feb 2019 & has been associated with this company since 6 years 9 months . was completed.
The activity Sunil Semwal was appointed as a Director was appointed as a Director on 18 Feb 2019 & has been associated with this company since 6 years 9 months . was completed.
Progress on Degenerica Pharmaceuticals Private Limited was registered on 18 Feb 2019 with Roc Uttarakhand & aged 6 years 9 months as per MCA records. was documented.
The CIN of Degenerica Pharmaceuticals Private Limited is U24294UR2019PTC009533.
Degenerica Pharmaceuticals Private Limited is headquartered at 1St Floor, Semwal Villa, Sarvpriya Vihar Lane No.2, Near Ugb Balawala, Dehradun, Uttarakhand, 248001.
Degenerica Pharmaceuticals Private Limited was incorporated on 18 February 2019.
The current directors of Degenerica Pharmaceuticals Private Limited are
The primary industry of Degenerica Pharmaceuticals Private Limited is Chemicals.
Degenerica Pharmaceuticals Private Limited is unlisted.
The authorized capital of Degenerica Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Degenerica Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX